SIRP alphaV2

SIRP alphaV2

SIRP alphaV2 분자 정보

Molecule Name
Signal-regulatory protein alpha
분자 별명
SHPS1,SIRPA,CD172A,BIT,MFR,MYD1,P84,PTPNS1
Drug Development Progress
임상 약물 수19
시판 약물 수2
최고 연구 개발 단계Approved
표적 별명
SHPS-1,Macrophage fusion receptor,Brain Ig-like molecule with tyrosine-based activation motifs,MFR,Signal-regulatory protein alpha-1,Signal-regulatory protein alpha-2,CD172a,MyD-1 antigen,Sirp-alpha-3,MYD1,SIRPA,Signal Regulatory Protein Alpha,CD172 Antigen-Like Family Member A,Inhibitory Receptor SHPS-1,PTPNS1,SHPS1,SIRP,P84,Brain-Immunoglobulin-Like Molecule With Tyrosine-Based Activation Motifs,Protein Tyrosine Phosphatase, Non-Receptor Type Substrate 1,Tyrosine-Protein Phosphatase Non-Receptor Type Substrate 1,Tyrosine Phosphatase SHP Substrate 1,Signal-Regulatory Protein Alpha-3,Signal-Regulatory Protein Alpha,SHP Substrate 1,CD172a Antigen,Sirp-Alpha-1,Sirp-Alpha-2,MYD-1,Bit,SIRPalpha,SIRPalpha2
분자 배경
Tyrosine-protein phosphatase non-receptor type substrate 1 (SHPS1) is also known as CD172 antigen-like family member A (CD172a), Macrophage fusion receptor, MyD-1 antigen, Signal-regulatory protein alpha (SIRPA or SIRP alpha) or p84, is a member of the SIRP family, and also belongs to the immunoglobulin superfamily. SIRP alpha is Ubiquitous and highly expressed in brain. SIRPA / CD172a is immunoglobulin-like cell surface receptor for CD47 and acts as docking protein and induces translocation of PTPN6, PTPN11 and other binding partners from the cytosol to the plasma membrane. SIRPA / SHPS-1 supports adhesion of cerebellar neurons, neurite outgrowth and glial cell attachment and may play a key role in intracellular signaling during synaptogenesis and in synaptic function By similarity. SIRPA / MyD1 involved in the negative regulation of receptor tyrosine kinase-coupled cellular responses induced by cell adhesion, growth factors or insulin and mediates negative regulation of phagocytosis, mast cell activation and dendritic cell activation. CD47 binding prevents maturation of immature dendritic cells and inhibits cytokine production by mature dendritic cells.

SIRP alphaV2 제품 목록

Species
  • Human(3)
Tag
  • His Tag(1)
  • His Tag & Avi Tag(1)
  • Llama IgG Fc Tag(1)
Host
  • HEK293(3)
Conjugate
  • Unconjugated(2)
  • Biotin-labeled(1)
Grade
  • RUO(3)
Low Endotoxin
  • Yes(2)
  • No(1)
분자Cat. No.Product Name종Host구조순도Activity규격 및 가격
SIRP alphaV2
HOTAvitag
SI2-H82W8
Biotinylated Human SIRP alphaV2 / CD172a Protein, His,Avitag™
Human
HEK293
SDS-PAGE
ELISA

$360.00

25ug
SIRP alphaV2
Human SIRP alphaV2 / CD172a Protein, His Tag, low endotoxin (MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISA

$360.00

100ug
SIRP alphaV2
Human SIRP alphaV2 / CD172a (31-148) Protein, Llama IgG2b Fc Tag, low endotoxin (MALS verified)
Human
HEK293
MALSSDS-PAGE
ELISA

$390.00

100ug
You Have Viewed 1-3 Of 3 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
IpsoprubartELA-026Phase 3 ClinicalElectra Therapeutics Inc
Lymphohistiocytosis, Hemophagocytic; Neoplasms
상세
LM-101LM-101Phase 2 ClinicalLaNova Medicines Ltd
Hematologic Neoplasms; Leukemia; Neoplasms; Solid tumours
상세
HX-044HX044; HX-044Phase 2 ClinicalHanx Biopharmaceuticals Pty Ltd
Lymphoma; Solid tumours
상세
BRB-002BRB-002Phase 2 ClinicalBitterroot Bio Inc
Atherosclerosis; Cardiovascular Diseases; Vasculitis
상세
BI-770371BI-770371Phase 2 ClinicalOse Immunotherapeutics
Carcinoma, Non-Small-Cell Lung; Liver Cirrhosis; Melanoma; Metabolic Dysfunction-Associated Steatotic Liver Disease; Solid tumours; Squamous Cell Carcinoma of Head and Neck
상세
IBC-0966IBC-0966Phase 2 Clinical
Neoplasms
상세
HX-009HX-009; HX009-II-02Phase 2 ClinicalWaterstone Hanxbio Pty Ltd
Bile Duct Neoplasms; Biliary Tract Neoplasms; Liver Neoplasms; Lymphoma; Melanoma; Solid tumours; Stomach Neoplasms; Triple Negative Breast Neoplasms
상세
BI-765063OSE-172; BI-765063; Effi-DEMPhase 1 ClinicalEffimune
Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Colorectal Neoplasms; Melanoma; Solid tumours; Squamous Cell Carcinoma of Head and Neck
상세
ADU-1805ADU-1805Phase 1 ClinicalAduro Biotech Inc
Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Colorectal Neoplasms; Endometrial Neoplasms; Neoplasms; Solid tumours
상세
Q-1801Q-1801; Q 1801Phase 1 ClinicalQure Biotechnology (Shanghai) Co Ltd
Solid tumours
상세
Recombinant humanized IgG4 anti-SIRPα antibody(Daiichi Sankyo)DS-1103aPhase 1 ClinicalDaiichi Sankyo Co Ltd
Breast Neoplasms; Solid tumours
상세
JY-47JY47; JY-47Phase 1 ClinicalHangzhou Jiuyuan Gene Biomedical Co Ltd
Liver Cirrhosis; Metabolic Dysfunction-Associated Steatotic Liver Disease; Solid tumours
상세
BYON-4228BYON-4228Phase 1 ClinicalSanquin Blood Supply Foundation
Lymphoma; Solid tumours
상세
BSI-082BSI-082Phase 1 ClinicalBiosion Inc
Hematologic Neoplasms; Neoplasm Metastasis; Solid tumours
상세
BR-105BR-105; BR105Phase 1 ClinicalHisun Biopharmaceutical Co Ltd, Zhejiang BioRay Biopharmaceuticals Co Ltd
Lymphoma, Large B-Cell, Diffuse; Neoplasms
상세
[89Zr]Zr- BI-765063(Boehringer Ingelheim)Phase 1 ClinicalBoehringer Ingelheim Corp
Carcinoma, Non-Small-Cell Lung; Melanoma; Squamous Cell Carcinoma of Head and Neck
상세
TQB-2928TQB-2928Phase 1 ClinicalJiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd
Carcinoma, Non-Small-Cell Lung; Hematologic Neoplasms; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Neoplasms; Osteosarcoma; Solid tumours
상세
BI-765080Phase 1 ClinicalC.H. Boehringer Sohn Ag & Co. Kg
상세
ES-004ES-004; ES 004-N4; ES 004-B4Phase 1 ClinicalElpiscience (Shanghai) Biopharma Ltd
Neoplasms; Solid tumours
상세

시판 약물 정보

영어 이름연구 코드연구 개발 단계회사가장 빠른 브랜드 이름가장 빠른 승인 국가가장 빠른 적응증가장 빠른 승인 회사가장 빠른 승인 날짜적응증임상 시험
Relugolix/Estradiol/Norethindrone AcetateE2/NETAApprovedMyovant SciencesMYFEMBREE, RYEQOUnited StatesMenorrhagia; LeiomyomaSumitomo Pharma America Inc, Myovant Sciences2021-05-26
Endometriosis; Leiomyoma; Menorrhagia; Pain; Uterine Neoplasms
상세
Elagolix/estradiol/norethindrone acetateApprovedAbbvie IncOriahnnUnited StatesMenorrhagiaAbbvie Inc2020-05-29
Menorrhagia
상세
Customer Reviews